Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

265 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Opportunities For Investment In The Chinese Health Care Market

    The purchasing power of the Chinese middle class is reshaping the world's market for luxury brands, tourism, real estate, and private investments.
    ChinaFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    The impact of the amended PRC Advertising Law on health-related advertisements

    The New Advertising Law strongly regulates advertisements of healthcare, medications, medical devices, and health food.
    ChinaMedia, Telecoms, IT, Entertainment
    King & Wood Mallesons
    King & Wood Mallesons
Article

Landmark Whistleblower Program For China's Healthcare Sector: Proposed Maximum Reward Of 1 Million RMB

On October 10, 2024, the National Medical Products Administration (NMPA) released the Draft Rule on Rewarding Internal Whistleblowers for Reporting on the Quality...
ChinaFood, Drugs, Healthcare, Life Sciences
Arnold & Porter
Arnold & Porter
  • Article

    Cheers Brita! Shanghai IP Court Thumbs Down Unauthorized Use Of BritaChina, EUBrita, And Brita's Chinese Brand As Seller Names On Alibaba Websites And WeChat

    While toilet paper sold out in the U.S., water filters got hot in China during the pandemic. A Chinese company decided to rip off the famous water filter brand...
    ChinaIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    What Legal Hurdles Will A Patent Application Of Coronavirus Cure Face?

    As researchers in the pharmaceutical industry seek to contain the novel coronavirus epidemic, Tao Xinliang, honorary dean of the Intellectual Property Institute of Shanghai University, shares with China Daily his insights into related patent issues.
    ChinaIntellectual Property
    AFD China
    AFD China
  • Article

    China Newsletter | Q3 2025/Issue No. 65

    This China Newsletter provides an overview of key developments in the following areas...
    ChinaStrategy
    Greenberg Traurig
    Greenberg Traurig
  • Article

    How Digital Therapeutics (DTx) Products Are Regulated In China?

    This article discusses the regulation of DTx products in China, the question of registration, and best practices for collecting and processing data through DTx products.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    First PRC stem cell clinical research rule

    These Administration Measures are China's first normative document on administrating stem cell clinical research.
    ChinaFood, Drugs, Healthcare, Life Sciences
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    China Releases 2025 Typical Cases On Patent Reexamination And Invalidation

    China's national intellectual property administration (CNIPA) has released ten typical cases from 2025 involving patent reexamination and invalidation. These cases were selected because they are highly relevant...
    ChinaIntellectual Property
    AFD China
    AFD China
  • Article

    Legal Perspective On COVID-19 Outbreak's Influence On Advertising Industry

    The outbreak of the novel coronavirus (Covid-19), which has yet to peak, has already had a significant impact in China on a macroeconomic and individual level. This article will look at how COVID-19 is affecting the advertising industry.
    ChinaMedia, Telecoms, IT, Entertainment
    Global Advertising Lawyers Alliance (GALA)
    Global Advertising Lawyers Alliance (GALA)
  • Article

    China Compliance Update: Life Sciences — Summer 2025

    This Advisory summarizes developments in the compliance environment for life sciences companies in China in the first half of 2025, following significant developments from 2024.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Virus And Patentability: Few Questions To The Expert

    For example, a DNA fragment that is designed by use of virus gene, synthetized and isolated, and aims for detecting the cases of the disease, can be patented.
    ChinaIntellectual Property
    HFG Law & Intellectual Property
    HFG Law & Intellectual Property
  • Article

    一表读懂"互联网+医疗"法律规范要点

    疫情之下,互联网医疗行业成功的扛起了疫情保卫战这面大旗。
    ChinaMedia, Telecoms, IT, Entertainment
    DeHeng Law Offices
    DeHeng Law Offices
  • Article

    ウェアラブルデバイスの市場競争が激化

    アップルは2014年9月、初代のスマートウォッチ「アップルウォッチ」を発表した。主に心拍数モニター、運動追跡、モバイル決済の3つの機能ӛ
    ChinaTechnology
    Kangxin
    Kangxin
  • Article

    China To Strengthen Regulation Of Human Genetic Resources

    Human genetic resources (HGR) have long been regulated in China under the Interim Measures for the Administration of HGR (人类遗传资源管理暂行办法) (Interim Measures)...
    ChinaFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
  • Article

    China Finalizes Regulations For Pharmaceutical Sales Representatives

    On May 7, 2026, China’s National Medical Products Administration (NMPA), in conjunction with six other government agencies, issued the Management Measures for Medical Representatives (Management Measures, 医药代表管理办法), which will take effect on August 1, 2026.
    ChinaCriminal Law
    Arnold & Porter
    Arnold & Porter
  • Article

    China Compliance Update: Life Sciences — Spring 2026

    Chinese regulators intensified anti-corruption enforcement in the life sciences sector during 2026, with particular emphasis on medical insurance fraud, investigator-initiated studies, and patient programs.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    China Introduces New Health Care Sector Anti-Corruption Regulations

    On December 26, 2013, the Commission promulgated Nine Prohibitions to Strengthen Ethical Conduct in the Healthcare Industry Circular [2013] No. 49.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Benesch Law
    Benesch Law
  • Article

    Implementing Rules on the PRC Food Safety Law

    The Implementing Rules on the PRC Food Safety Law ("Food Safety Rules") became effective on 20 July 2009, the date of their promulgation by the PRC State Council.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Beiten Burkhardt
    Beiten Burkhardt
  • Article

    Spotlight On China's Hospital System

    Hospitals in China differ greatly from those in the west with respect to their relationships with physicians and patients; but they also share some of the same legal challenges faced by western hospitals.
    ChinaFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Showing 101–120 of 265 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics